Trials / Completed
CompletedNCT01457352
Efficacy and Safety of SPARC0921 in Subjects With Spasticity
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 392 (actual)
- Sponsor
- Sun Pharma Advanced Research Company Limited · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess whether SPARC0921 demonstrate efficacy and safety in the treatment of spasticity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SPARC0921 | |
| DRUG | Placebo0921 |
Timeline
- Start date
- 2012-11-14
- Primary completion
- 2017-08-25
- Completion
- 2017-08-25
- First posted
- 2011-10-21
- Last updated
- 2019-06-18
- Results posted
- 2019-06-18
Locations
73 sites across 5 countries: United States, Germany, Hungary, Russia, Ukraine
Source: ClinicalTrials.gov record NCT01457352. Inclusion in this directory is not an endorsement.